• America Great Health posted a net loss of $85,363 for the quarter ended Sept. 30, 2025, narrowing from $146,967 a year earlier.
• Sales rose to $187,559 from $140,126, driven by two large wholesale orders tied to new product launches.
• Gross profit slipped to $112,679 from $128,791 as costs of goods sold climbed to $74,880 from $11,335 on wholesale mix.
• Operating expenses fell to $116,063 from $199,650, reflecting lower payroll, auditing, and professional fees.
• Cash ended the quarter at $28,079; management flagged substantial doubt about going concern, with funding needs met mainly by shareholder loans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. America Great Health published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-002331), on June 04, 2026, and is solely responsible for the information contained therein.